Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Existe información en español para pacientes y cuidadores, para acceder, haga clic sobre “Select” al lado de “I am a U.S. Patient / Caregiver”.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

atracurium besylate injection, USP Principal Display Panel

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label

NDC 0409-1105-22

Atracurium
Besylate Injection USP

100 mg/10 mL
(10 mg/mL)

WARNING: Paralyzing Agent

FOR INTRAVENOUS INJECTION
Sterile, non-pyrogenic

Rx only

Hospira

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label

PRINCIPAL DISPLAY PANEL - 10 mL Vial Carton

NDC 0409-1105-02
Contains 10 of NDC 0409-1105-22

10 x 10 mL Multiple Dose Vials

Atracurium Besylate Injection USP

100 mg/10 mL
(10 mg/mL)

WARNING: Paralyzing Agent

FOR INTRAVENOUS INJECTION
Sterile, non-pyrogenic

Rx only

Hospira

PRINCIPAL DISPLAY PANEL - 10 mL Vial Carton

PRINCIPAL DISPLAY PANEL - 5 mL Vial Label

NDC 0409-1109-11

Atracurium
Besylate Injection USP

50 mg/5 mL
(10 mg/mL)

WARNING: Paralyzing Agent

FOR INTRAVENOUS INJECTION
Sterile, non-pyrogenic

Rx only

Hospira

PRINCIPAL DISPLAY PANEL - 5 mL Vial Label

PRINCIPAL DISPLAY PANEL - 5 mL Vial Carton

NDC 0409-1109-01
Contains 10 of NDC 0409-1109-11

10 x 5 mL Single Dose Vials

Atracurium Besylate Injection USP

50 mg/5 mL
(10 mg/mL)

WARNING: Paralyzing Agent

FOR INTRAVENOUS INJECTION
Sterile, non-pyrogenic

Rx only

Hospira

PRINCIPAL DISPLAY PANEL - 5 mL Vial Carton
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event